A
Alpha Tau Medical Ltd
NASDAQ:DRTS
Alpha Tau Medical Ltd
NASDAQ:DRTS
Price:
7.17
USD
2.87%
Market Closed
Market Cap:
$611.3m
Alpha Tau Medical Ltd
EPS (Diluted)
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Alpha Tau Medical Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
EPS (Diluted)
$0
|
CAGR 3-Years
0%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
EPS (Diluted)
$0
|
CAGR 3-Years
11%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inmode Ltd
NASDAQ:INMD
|
EPS (Diluted)
$1
|
CAGR 3-Years
-9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Sisram Medical Ltd
HKEX:1696
|
EPS (Diluted)
$0
|
CAGR 3-Years
-21%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
EPS (Diluted)
$0
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Alpha Tau Medical Ltd
Glance View
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
DRTS
Intrinsic Value
0.88
USD
Overvaluation 88%
A
See Also
What is Alpha Tau Medical Ltd's EPS (Diluted)?
EPS (Diluted)
-0.5
USD
-0.5
USD
Based on the financial report for Dec 31, 2025, Alpha Tau Medical Ltd's EPS (Diluted) amounts to -0.5 USD.
What is Alpha Tau Medical Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-32%
-32%
Over the last year, the EPS (Diluted) growth was -18%.
